CAN NOVEL AGENTS OVERCOME THE NEGATIVE PROGNOSTIC IMPACT OF RENAL IMPAIRMENT IN MULTIPLE MYELOMA? - A POPULATION BASED STUDY INCLUDING 1538 PATIENTS

被引：0
|
作者：
Uttervall, K. [1 ]
Lund, J. [1 ]
Liwing, J. [1 ]
Holmberg, E. [2 ]
Alici, E. [1 ]
Aschan, J. [3 ]
Nahi, H. [1 ]
机构：
[1] Karolinska Inst, Dept Med, Stockholm, Sweden
[2] Univ Gothenburg, Dept Oncol, Inst Clin Sci, Sahlgrenska Acad, Gothenburg, Sweden
[3] Janssen Cilag AB, Sollentuna, Sweden
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P781
引用
收藏
页码：326 / 327
页数：2
相关论文
共 50 条
  • [1] Is Renal Impairment Still a Poor Prognostic Marker in Myeloma Care?: A Population Based Study Including 1542 Patients
    Uttervall, Katarina
    Andreasson, Johan
    Liwing, Johan
    Nasman, Per
    Aschan, Johan
    Nahi, Hareth
    BLOOD, 2012, 120 (21)
  • [2] Incidence, prognostic impact and clinical outcomes of renal impairment in patients with multiple myeloma: a population-based registry
    Courant, Maxime
    Orazio, Sebastien
    Monnereau, Alain
    Preterre, Julie
    Combe, Christian
    Rigothier, Claire
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (03) : 482 - 490
  • [3] Novel Therapeutic Agents for the Management of Patients with Multiple Myeloma and Renal Impairment
    Chanan-Khan, Asher A.
    San Miguel, Jesus F.
    Jagannath, Sundar
    Ludwig, Heinz
    Dimopoulos, Meletios A.
    CLINICAL CANCER RESEARCH, 2012, 18 (08) : 2145 - 2163
  • [4] Reversal of Renal Function and Its Prognostic Impact in Patients with Multiple Myeloma in the Era of Novel Agents
    Narita, Kentaro
    Usui, Yoshiaki
    Suehara, Yasuhito
    Fukumoto, Kota
    Fujisawa, Manabu
    Takeuchi, Masami
    Matsue, Kosei
    BLOOD, 2015, 126 (23)
  • [5] Novel Agents Overcome the Adverse Prognosis Imparted by Compromised Renal Function in Patients with Multiple Myeloma.
    Patel, Mehul
    Sher, Taimur
    Ailawadhi, Sikander
    Mashtare, Terry, Jr.
    Tan, Wei
    Soni, Pranay
    Wilding, Gregory
    Miller, Kena C.
    Mohr, Alice
    Lee, Kelvin P.
    Chanan-Khan, Asher Alban
    BLOOD, 2008, 112 (11) : 942 - 942
  • [6] The impact of the introduction of bortezomib on dialysis independence in multiple myeloma patients with renal impairment: a nationwide Dutch population-based study
    Oortgiesen, Berdien E.
    Azad, Roshna
    Hemmelder, Marc H.
    Kibbelaar, Robby E.
    Veeger, Nic J. G. M.
    de Vries, Joost C.
    van Roon, Eric N.
    Hoogendoorn, Mels
    HAEMATOLOGICA, 2018, 103 (07) : E311 - E314
  • [7] The use of novel agents in multiple myeloma patients with hepatic impairment
    Stansfield, Lindsay C.
    Gonsalves, Wilson I.
    Buadi, Francis K.
    FUTURE ONCOLOGY, 2015, 11 (03) : 501 - 510
  • [8] The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma
    M A Dimopoulos
    M Roussou
    M Gkotzamanidou
    N Nikitas
    E Psimenou
    D Mparmparoussi
    C Matsouka
    M Spyropoulou-Vlachou
    E Terpos
    E Kastritis
    Leukemia, 2013, 27 : 423 - 429
  • [9] The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma
    Dimopoulos, M. A.
    Roussou, M.
    Gkotzamanidou, M.
    Nikitas, N.
    Psimenou, E.
    Mparmparoussi, D.
    Matsouka, C.
    Spyropoulou-Vlachou, M.
    Terpos, E.
    Kastritis, E.
    LEUKEMIA, 2013, 27 (02) : 423 - 429
  • [10] Bortezomib overcomes the negative prognostic impact of renal impairment in a newly diagnosed elderly patient with multiple myeloma: A case report
    Wu, Tao
    Zhou, Jinmao
    Wang, Cunbang
    Wang, Binbin
    Zhang, Shuting
    Bai, Hai
    ONCOLOGY LETTERS, 2017, 14 (06) : 7318 - 7322
12345